Literature DB >> 23175695

Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling.

Anoop K Shetty1, Simon G Duckett, Matthew R Ginks, Yinglaing Ma, Manav Sohal, Julian Bostock, Stam Kapetanakis, Jagmeet P Singh, Kawal Rhode, Matthew Wright, Mark D O'Neill, Jaswinder S Gill, Gerald Carr-White, Reza Razavi, Christopher Aldo Rinaldi.   

Abstract

AIMS: Left ventricular (LV) lead positioning for cardiac resynchronization therapy (CRT) is largely empirical and operator-dependent. Our aim was to determine whether cardiac magnetic resonance (CMR)-guided CRT may improve the acute and the chronic response. METHODS AND
RESULTS: CMR-derived anatomical models and dyssynchrony maps were created for 20 patients. The CMR targets (three latest activated segments with <50% scar) were overlaid on to live fluoroscopy. Acute haemodynamic response (AHR) to LV pacing was assessed using an intra-ventricular pressure wire. Chronic CRT response (end-systolic volume reduction ≥15%) was assessed 6 months post-implantation. All patients underwent successful CMR-guided LV lead placement. A CMR target segment was paced in 75% of patients. The mean change in LVdP/dtmax for the CMR target was +14.2 ± 12.5 vs. +18.7 ± 11.9% for the best AHR in any segment and +12.0 ± 13.8% for the segment based on coronary sinus (CS) venography. Using CMR guidance, the acute responder rate was 60 vs. 50% on the basis of venography. At 6 months 60% of patients were echocardiographic responders. Of the echocardiographic responders, 92% were successfully paced in a CMR target segment compared with only 50% of non-responders (P = 0.04).
CONCLUSION: CMR guidance compared well when validated against the AHR. Lead placement was possible in the CMR target region in most patients with an AHR comparable with the best achieved in any CS branch. The chronic response was significantly better in patients paced in a CMR target segment. These results suggest that CMR guidance may represent a clinically useful tool for CRT.

Entities:  

Keywords:  Cardiac resynchronization therapy; Haemodynamics; Heart failure; Imaging; Magnetic resonance imaging

Mesh:

Year:  2012        PMID: 23175695     DOI: 10.1093/ehjci/jes270

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  19 in total

Review 1.  Updates in Cardiac Resynchronization Therapy for Chronic Heart Failure: Review of Multisite Pacing.

Authors:  Antonios P Antoniadis; Ben Sieniewicz; Justin Gould; Bradley Porter; Jessica Webb; Simon Claridge; Jonathan M Behar; Christopher Aldo Rinaldi
Journal:  Curr Heart Fail Rep       Date:  2017-10

2.  Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.

Authors:  Mei Methawasin; Joshua G Strom; Rebecca E Slater; Vanessa Fernandez; Chandra Saripalli; Henk Granzier
Journal:  Circulation       Date:  2016-09-14       Impact factor: 29.690

Review 3.  Recent advances in the optimization of cardiac resynchronization therapy.

Authors:  Satish Chandraprakasam; Gina G Mentzer
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 4.  Multisite Pacing for Cardiac Resynchronization Therapy: Promise and Pitfalls.

Authors:  Antonios P Antoniadis; Jonathan M Behar; Simon Claridge; Tom Jackson; Manav Sohal; Christopher Aldo Rinaldi
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

Review 5.  Image-guided left ventricular lead placement in cardiac resynchronization therapy: focused on image fusion methods.

Authors:  Premysl Hajek; Iva Safarikova; Jan Baxa
Journal:  J Appl Biomed       Date:  2019-12-11       Impact factor: 1.797

6.  Prediction of Cardiac Resynchronization Therapy Response Using a Lead Placement Score Derived From 4-Dimensional Computed Tomography.

Authors:  Ashish Manohar; Gabrielle M Colvert; James Yang; Zhennong Chen; Maria J Ledesma-Carbayo; Mads Brix Kronborg; Anders Sommer; Bjarne L Nørgaard; Jens Cosedis Nielsen; Elliot R McVeigh
Journal:  Circ Cardiovasc Imaging       Date:  2022-08-16       Impact factor: 8.589

Review 7.  The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy - a systematic review of the literature.

Authors:  George Bazoukis; Jeremy Man Ho Hui; Yan Hiu Athena Lee; Oscar Hou In Chou; Dimitrios Sfairopoulos; Konstantinos Vlachos; Athanasios Saplaouras; Konstantinos P Letsas; Michael Efremidis; Gary Tse; Vassilios S Vassiliou; Panagiotis Korantzopoulos
Journal:  Heart Fail Rev       Date:  2022-08-31       Impact factor: 4.654

8.  Prediction of response to cardiac resynchronization therapy using left ventricular pacing lead position and cardiovascular magnetic resonance derived wall motion patterns: a prospective cohort study.

Authors:  Gregory R Hartlage; Jonathan D Suever; Stephanie Clement-Guinaudeau; Patrick T Strickland; Nima Ghasemzadeh; R Patrick Magrath; Ankit Parikh; Stamatios Lerakis; Michael H Hoskins; Angel R Leon; Michael S Lloyd; John N Oshinski
Journal:  J Cardiovasc Magn Reson       Date:  2015-07-14       Impact factor: 5.364

9.  Optimized Left Ventricular Endocardial Stimulation Is Superior to Optimized Epicardial Stimulation in Ischemic Patients With Poor Response to Cardiac Resynchronization Therapy: A Combined Magnetic Resonance Imaging, Electroanatomic Contact Mapping, and Hemodynamic Study to Target Endocardial Lead Placement.

Authors:  Jonathan M Behar; Tom Jackson; Eoin Hyde; Simon Claridge; Jaswinder Gill; Julian Bostock; Manav Sohal; Bradley Porter; Mark O'Neill; Reza Razavi; Steve Niederer; Christopher Aldo Rinaldi
Journal:  JACC Clin Electrophysiol       Date:  2016-12

10.  The impact of beat-to-beat variability in optimising the acute hemodynamic response in cardiac resynchronisation therapy.

Authors:  Steven Niederer; Cameron Walker; Andrew Crozier; Eoin R Hyde; Bojan Blazevic; Jonathan M Behar; Simon Claridge; Manav Sohal; Anoop Shetty; Tom Jackson; Christopher Rinaldi
Journal:  Clin Trials Regul Sci Cardiol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.